Polyethylene glycol explained

Polyethylene glycol (PEG;) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH.

Uses

Medical uses

See main article: Macrogol and PEGylation.

Chemical uses

Biological uses

Commercial uses

Industrial uses

Entertainment uses

Health effects

PEG is considered biologically inert and safe by the U.S. FDA.

A 2015 study used a high-sensitivity ELISA assay to detect anti-PEG antibodies in 72% of plasma samples collected from 1990–1999, suggesting that anti-PEG antibodies may be present (typically at low levels) even amongst people never treated with PEGylated drugs.[35] [36] Due to its ubiquity in a multitude of products and the large percentage of the population with antibodies to PEG, hypersensitive reactions to PEG are an increasing concern.[37] [38] Allergy to PEG is usually discovered after a person has been diagnosed with an allergy to an increasing number of seemingly unrelated products, including processed foods, cosmetics, drugs, and other substances that contain PEG or were manufactured with PEG.

Available forms and nomenclature

PEG, PEO, and POE refer to an oligomer or polymer of ethylene oxide. The three names are chemically synonymous, but historically PEG is preferred in the biomedical field, whereas PEO is more prevalent in the field of polymer chemistry. Because different applications require different polymer chain lengths, PEG has tended to refer to oligomers and polymers with a molecular mass below 20,000g/mol, PEO to polymers with a molecular mass above 20,000g/mol, and POE to a polymer of any molecular mass.[39] PEGs are prepared by polymerization of ethylene oxide and are commercially available over a wide range of molecular weights from 300g/mol to 10,000,000g/mol.

PEG and PEO are liquids or low-melting solids, depending on their molecular weights. While PEG and PEO with different molecular weights find use in different applications, and have different physical properties (e.g. viscosity) due to chain length effects, their chemical properties are nearly identical. Different forms of PEG are also available, depending on the initiator used for the polymerization process – the most common initiator is a monofunctional methyl ether PEG, or methoxypoly(ethylene glycol), abbreviated mPEG. Lower-molecular-weight PEGs are also available as purer oligomers, referred to as monodisperse, uniform, or discrete. Very high-purity PEG has recently been shown to be crystalline, allowing determination of a crystal structure by x-ray crystallography.[40] Since purification and separation of pure oligomers is difficult, the price for this type of quality is often 10–1000 fold that of polydisperse PEG.

PEGs are also available with different geometries.

The numbers that are often included in the names of PEGs indicate their average molecular weights (e.g. a PEG with would have an average molecular weight of approximately 400 daltons, and would be labeled PEG 400). Most PEGs include molecules with a distribution of molecular weights (i.e. they are polydisperse). The size distribution can be characterized statistically by its weight average molecular weight (Mw) and its number average molecular weight (Mn), the ratio of which is called the polydispersity index (ĐM). Mw and Mn can be measured by mass spectrometry.

PEGylation is the act of covalently coupling a PEG structure to another larger molecule, for example, a therapeutic protein, which is then referred to as a PEGylated protein. PEGylated interferon alfa-2a or alfa-2b are commonly used injectable treatments for hepatitis C infection.

PEG is soluble in water, methanol, ethanol, acetonitrile, benzene, and dichloromethane, and is insoluble in diethyl ether and hexane. It is coupled to hydrophobic molecules to produce non-ionic surfactants.[41]

PEG and related polymers (PEG phospholipid constructs) are often sonicated when used in biomedical applications. However, as reported by Murali et al., PEG is very sensitive to sonolytic degradation and PEG degradation products can be toxic to mammalian cells. It is, thus, imperative to assess potential PEG degradation to ensure that the final material does not contain undocumented contaminants that can introduce artifacts into experimental results.[42]

PEGs and methoxypolyethylene glycols are manufactured by Dow Chemical under the trade name Carbowax for industrial use, and Carbowax Sentry for food and pharmaceutical use. They vary in consistency from liquid to solid, depending on the molecular weight, as indicated by a number following the name. They are used commercially in numerous applications, including foods, in cosmetics, in pharmaceutics, in biomedicine, as dispersing agents, as solvents, in ointments, in suppository bases, as tablet excipients, and as laxatives. Some specific groups are lauromacrogols, nonoxynols, octoxynols, and poloxamers.

Production

The production of polyethylene glycol was first reported in 1859. Both A. V. Lourenço and Charles Adolphe Wurtz independently isolated products that were polyethylene glycols.[43] Polyethylene glycol is produced by the interaction of ethylene oxide with water, ethylene glycol, or ethylene glycol oligomers.[44] The reaction is catalyzed by acidic or basic catalysts. Ethylene glycol and its oligomers are preferable as a starting material instead of water, because they allow the creation of polymers with a low polydispersity (narrow molecular weight distribution). Polymer chain length depends on the ratio of reactants.

HOCH2CH2OH + n(CH2CH2O) → HO(CH2CH2O)n+1H

Depending on the catalyst type, the mechanism of polymerization can be cationic or anionic. The anionic mechanism is preferable because it allows one to obtain PEG with a low polydispersity. Polymerization of ethylene oxide is an exothermic process. Overheating or contaminating ethylene oxide with catalysts such as alkalis or metal oxides can lead to runaway polymerization, which can end in an explosion after a few hours.

Polyethylene oxide, or high-molecular-weight polyethylene glycol, is synthesized by suspension polymerization. It is necessary to hold the growing polymer chain in solution in the course of the polycondensation process. The reaction is catalyzed by magnesium-, aluminium-, or calcium-organoelement compounds. To prevent coagulation of polymer chains from solution, chelating additives such as dimethylglyoxime are used.

Alkaline catalysts such as sodium hydroxide (NaOH), potassium hydroxide (KOH), or sodium carbonate (Na2CO3) are used to prepare low-molecular-weight polyethylene glycol.[45]

Safety

PEO's have "very low singledose oral toxicity", on the order of tens of grams per kg body weight (oral). Because of its low toxicity, PEO is used in a variety of edible products.[46] The polymer is used as a lubricating coating for various surfaces in aqueous and non-aqueous environments.[47]

The precursor to PEGs is ethylene oxide, which is hazardous.[48] Ethylene glycol and its ethers are nephrotoxic if applied to damaged skin.[49]

See also

External links

Notes and References

  1. Web site: Polyethylene Glycol as Pharmaceutical Excipient . 2021-04-27 . pharmaceutical.basf.com . en.
  2. Web site: Polyethyleneglycol (PEG 4000) Laxolite Medical Dialogues . . 19 January 2021 . 19 January 2021.
  3. Ma Y, Ji Y, Zhong T, Wan W, Yang Q, Li A, Zhang X, Lin M . 6 . Bioprinting-Based PDLSC-ECM Screening for in Vivo Repair of Alveolar Bone Defect Using Cell-Laden, Injectable and Photocrosslinkable Hydrogels . ACS Biomaterials Science & Engineering . 3 . 12 . 3534–3545 . December 2017 . 33445388 . 10.1021/acsbiomaterials.7b00601 .
  4. Seregin SS, Amalfitano A . Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors . . 9 . 12 . 1521–1531 . 2009 . 10.1517/14712590903307388 . 19780714 . 21927486 .
  5. Cabanillas B, Akdis CA, Novak N . Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol? . Allergy . 76 . 6 . 1617–1618 . June 2021 . 33320974 . 10.1111/all.14711 . 229284320 . free .
  6. Web site: Bostock N . GP . MHRA warning after allergic reactions in NHS staff given COVID-19 vaccine . 9 December 2020 . 9 December 2020 . 9 December 2020 . https://web.archive.org/web/20201209163321/https://www.gponline.com/mhra-warning-allergic-reactions-nhs-staff-given-covid-19-vaccine/article/1702322 . live . vanc .
  7. Web site: Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies . Health Canada . 12 December 2020.
  8. News: Furtula A, Jordans F . EU regulator gives conditional approval to Pfizer-BioNTech COVID-19 vaccine . Reuters . The Globe and Mail Inc . 21 December 2020.
  9. Book: Kvarning LÅ, Ohrelius B . 1998 . The Vasa – The Royal Ship . 91-7486-581-1 . 133–141 . Atlantis .
  10. Web site: Anti-Freeze is Not a Green Wood Stabilizer – Buzz Saw . The Rockler Blog . https://web.archive.org/web/20220117170449/https://www.rockler.com/anti-freeze-is-not-a-green-wood-stabilizer . 17 January 2022 . 2 May 2006 . 30 November 2012 .
  11. Web site: Conservators preserve the paint layers of the Terracotta Army . Reiffert S . 18 March 2015 . tum.de . Technische Universität München . 19 December 2015 . 22 December 2015 . https://web.archive.org/web/20151222113322/https://www.tum.de/en/about-tum/news/press-releases/short/article/32290/ . dead .
  12. Terra-Cotta Warriors in Color . . June 2012 . Larmer B . 221 . 6 . 74–87.
  13. Rameez S, Alosta H, Palmer AF . Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier . Bioconjugate Chemistry . 19 . 5 . 1025–32 . May 2008 . 18442283 . 10.1021/bc700465v .
  14. Web site: Facts: Polaris Poseidon Trident. Strategic Systems Programs. U.S. Navy.
  15. Firouzabadi H, Iranpoor N, Gholinejad M . One-Pot Thioetherification of Aryl Halides Using Thiourea and Alkyl Bromides Catalyzed by Copper(I) Iodide Free from Foul-Smelling Thiols in Wet Polyethylene Glycol (PEG 200). Advanced Synthesis & Catalysis . 352 . 18 . 119-24 . January 2010 . 10.1002/adsc.200900671.
  16. Moore EM, Ying G, West JL . March 2017. Macrophages Influence Vessel Formation in 3D Bioactive Hydrogels. Advanced Biosystems . en . 1. 3. 1600021. 10.1002/adbi.201600021. 102369711. free.
  17. Ganji M, Docter M, Le Grice SF, Abbondanzieri EA . DNA binding proteins explore multiple local configurations during docking via rapid rebinding . Nucleic Acids Research . 44 . 17 . 8376–8384 . September 2016 . 27471033 . 5041478 . 10.1093/nar/gkw666 .
  18. Bielec K, Kowalski A, Bubak G, Witkowska Nery E, Hołyst R . Ion Complexation Explains Orders of Magnitude Changes in the Equilibrium Constant of Biochemical Reactions in Buffers Crowded by Nonionic Compounds . The Journal of Physical Chemistry Letters . 13 . 1 . 112–117 . January 2022 . 34962392 . 8762655 . 10.1021/acs.jpclett.1c03596 .
  19. Breton MF, Discala F, Bacri L, Foster D, Pelta J, Oukhaled A . 2013-07-03 . Exploration of Neutral Versus Polyelectrolyte Behavior of Poly(ethylene glycol)s in Alkali Ion Solutions using Single-Nanopore Recording . The Journal of Physical Chemistry Letters . en . 4 . 13 . 2202–2208 . 10.1021/jz400938q . 1948-7185.
  20. Kreppel F, Kochanek S . Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide . Molecular Therapy . 16 . 1 . 16–29 . January 2008 . 17912234 . 10.1038/sj.mt.6300321 . free .
  21. Rossi JJ . RNAi therapeutics: SNALPing siRNAs in vivo . Gene Therapy . 13 . 7 . 583–584 . April 2006 . 17526070 . 10.1038/sj.gt.3302661 . 7232293 . free .
  22. Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I . 6 . Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study . Lancet . 375 . 9729 . 1896–1905 . May 2010 . 20511019 . 7138079 . 10.1016/S0140-6736(10)60357-1 . (free with registration)
  23. Book: Harmening DM . Modern Blood Banking & Transfusion Practices . F. A. Davis Company . 2005 . 978-0-8036-1248-8.
  24. Monteiro-Riviere NA, Inman AO, Jackson H, Dunn B, Dimond S . Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin . Toxicology and Industrial Health . 17 . 4 . 95–104 . May 2001 . 12479505 . 10.1191/0748233701th095oa . 46229131 .
  25. Krasilnikov OV, Sabirov RZ, Ternovsky VI, Merzliak PG, Muratkhodjaev JN . A simple method for the determination of the pore radius of ion channels in planar lipid bilayer membranes . FEMS Microbiology Immunology . 5 . 1–3 . 93–100 . September 1992 . 1384601 . 10.1016/0378-1097(92)90079-4 . free .
  26. Bárcena-Uribarri I, Thein M, Maier E, Bonde M, Bergström S, Benz R . Use of nonelectrolytes reveals the channel size and oligomeric constitution of the Borrelia burgdorferi P66 porin . PLOS ONE . 8 . 11 . e78272 . 2013 . 24223145 . 3819385 . 10.1371/journal.pone.0078272 . free . 2013PLoSO...878272B .
  27. Kean S . Chemical Hope. Distillations. 2017. 2. 4. 5. 22 March 2018.
  28. News: BBC News. 1 September 2002. Tattoo to monitor diabetes.
  29. US Government – Food and Drug Agency Web site: Food Additive Status List . . 2 May 2017.
  30. Web site: Codex Alimentarius . codexalimentarius.net . unfit . https://web.archive.org/web/20120107123157/http://www.codexalimentarius.net/web/index_en.jsp . 7 January 2012 .
  31. Web site: Current EU approved additives and their E Numbers . 21 October 2010. UK Government – Food Standards Agency.
  32. Book: Spinardi G . From Polaris to Trident : the development of US fleet ballistic missile technology. limited. 1994. Cambridge Univ. Press. Cambridge. 978-0-521-41357-2. 159.
  33. Ueno K, Nakamura S, Shimotani H, Ohtomo A, Kimura N, Nojima T, Aoki H, Iwasa Y, Kawasaki M . 6 . Electric-field-induced superconductivity in an insulator . Nature Materials . 7 . 11 . 855–8 . November 2008 . 18849974 . 10.1038/nmat2298 . 2008NatMa...7..855U .
  34. Schneider, Samuel J. (1991) Engineered Materials Handbook: Ceramics and Glasses, Vol. 4. ASM International. . p. 49.
  35. Yang Q, Lai SK . Anti-PEG immunity: emergence, characteristics, and unaddressed questions . Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology . 7 . 5 . 655–77 . 2015 . 25707913 . 4515207 . 10.1002/wnan.1339 .
  36. Yang . Qi . Jacobs . Timothy M. . McCallen . Justin D. . Moore . Dominic T. . Huckaby . Justin T. . Edelstein . Jasmine N. . Lai . Samuel K. . Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population . Analytical Chemistry . 16 November 2016 . 88 . 23 . 11804–11812 . 0003-2700 . 1520-6882 . 10.1021/acs.analchem.6b03437 . 27804292 . 6512330 .
  37. Wenande E, Garvey LH . Immediate-type hypersensitivity to polyethylene glycols: a review . Clinical and Experimental Allergy . 46 . 7 . 907–22 . July 2016 . 27196817 . 10.1111/cea.12760 . 1247758 .
  38. Stone CA, Liu Y, Relling MV, Krantz MS, Pratt AL, Abreo A, Hemler JA, Phillips EJ . 6 . Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized . The Journal of Allergy and Clinical Immunology. In Practice . 7 . 5 . 1533–1540.e8 . May 2019 . 30557713 . 6706272 . 10.1016/j.jaip.2018.12.003 .
  39. For example, in the online catalog of Scientific Polymer Products, Inc., poly(ethylene glycol) molecular weights run up to about 20,000, while those of poly(ethylene oxide) have six or seven digits.
  40. French AC, Thompson AL, Davis BG . High-purity discrete PEG-oligomer crystals allow structural insight . Angewandte Chemie . 48 . 7 . 1248–52 . 2009 . 19142918 . 10.1002/anie.200804623 .
  41. Force-field dependence of the conformational properties of α,ω-dimethoxypolyethylene glycol. Molecular Physics. 107. 13. 1313–1321. 10.1080/00268970902794826. 2009. Winger M, De Vries AH, Van Gunsteren WF . 2009MolPh.107.1313W. 10072/37876. 97215923. free.
  42. Murali VS, Wang R, Mikoryak CA, Pantano P, Draper R . Rapid detection of polyethylene glycol sonolysis upon functionalization of carbon nanomaterials . Experimental Biology and Medicine . 240 . 9 . 1147–51 . September 2015 . 25662826 . 4527952 . 10.1177/1535370214567615 .
  43. Book: Bailey FE, Koleske JV . Alkylene oxides and their polymers. 1990. Dekker. New York. 9780824783846. 27–28. 17 July 2017.
  44. http://chemindustry.ru/Polyethylene_Glycol.php Polyethylene glycol
  45. Web site: PEG 4000, 6000, 8000, 12000 Polyethylene glycol . 2023-01-19 . www.venus-goa.com . en.
  46. Book: Sheftel VO. Indirect Food Additives and Polymers: Migration and Toxicology. 2000. 1114–1116. CRC. 22 August 2007. 9 August 2007. https://web.archive.org/web/20070809043819/http://www.mindfully.org/Plastic/Polymers/Polyethylene-Glycols-PEGs.htm. dead.
  47. Nalam PC, Clasohm JN, Mashaghi A, Spencer ND . 10.1007/s11249-009-9549-9. Macrotribological Studies of Poly(L-lysine)-graft-Poly(ethylene glycol) in Aqueous Glycerol Mixtures. 2009 . 109928127. Tribology Letters. 37. 3. 541–552. 20.500.11850/17055. Submitted manuscript. free.
  48. Web site: Potential Contaminants - 1,4-Dioxane A Manufacturing Byproduct . Center for Food Safety and Applied Nutrition . fda.gov. en. 2017-05-26.
  49. Special Report: Reproductive and Developmental Toxicity of Ethylene Glycol and Its Ethers. International Journal of Toxicology . 18 . 3 . 53–67. 1999 . 10.1177/109158189901800208 . Andersen FA . 86231595 . free .